End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.496 PLN | 0.00% | -0.80% | +45.88% |
14/02 | Stem Cells Spin S.A. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 | CI |
14/02 | Stem Cells Spin S.A. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Sales 2021 | 526K 130K 10.87M | Sales 2022 | 248K 61.57K 5.13M | Capitalization | 11.57M 2.87M 239M |
---|---|---|---|---|---|
Net income 2021 | - 0 0 | Net income 2022 | - 0 0 | EV / Sales 2021 | 56.8 x |
Net Debt 2021 | 338K 83.69K 6.98M | Net Debt 2022 | 400K 99.25K 8.28M | EV / Sales 2022 | 48.2 x |
P/E ratio 2021 |
-232
x | P/E ratio 2022 |
435
x | Employees | 1 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 10.62% |
1 week | -0.80% | ||
Current month | +5.53% | ||
1 month | +3.33% | ||
3 months | +24.00% | ||
6 months | +48.50% | ||
Current year | +45.88% |
Managers | Title | Age | Since |
---|---|---|---|
Adam Symber
CEO | Chief Executive Officer | 43 | 01/10/01 |
Chairman | 81 | - | |
Andrzej Kryzar
BRD | Director/Board Member | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 81 | - | |
Director/Board Member | 71 | - | |
Director/Board Member | 62 | - |
Date | Price | Change | Volume |
---|---|---|---|
25/24/25 | 0.496 | 0.00% | 678 |
24/24/24 | 0.496 | -0.80% | 50 |
23/24/23 | 0.5 | 0.00% | 50 |
22/24/22 | 0.5 | 0.00% | 90 |
19/24/19 | 0.5 | -4.76% | 9,488 |
End-of-day quote Warsaw S.E., April 25, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
+45.88% | 5.06M | |
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- SCS Stock